|4May 2, 4:25 PM ET

Larson Betty D 4

4 · Merck & Co., Inc. · Filed May 2, 2024

Insider Transaction Report

Form 4
Period: 2024-04-30
Larson Betty D
EVP, Chief HR Officer
Transactions
  • Award

    Restricted Stock Unit

    2024-04-30+34,05034,050 total
    From: 2025-04-30Exp: 2027-04-30Common Stock (34,050 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-04-30+58,59458,594 total
    Exercise: $129.22From: 2025-04-30Exp: 2034-04-29Common Stock (58,594 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-04-30+31,05531,055 total
    Exercise: $129.22From: 2025-04-30Exp: 2034-04-29Common Stock (31,055 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
  • [F2]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.
  • [F3]The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.

Documents

2 files
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY